(Q45037103)

8 December 2017

title

Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent (English)

1 reference

8 December 2017

0 references

8

1 reference

8 December 2017

Charles Thomas

2

0 references

author name string

Jean-François Landrier

1

1 reference

8 December 2017

Jacques Grober

3

1 reference

8 December 2017

Hélène Duez

4

1 reference

8 December 2017

Frédéric Percevault

5

1 reference

8 December 2017

Maâmar Souidi

6

1 reference

8 December 2017

Christine Linard

7

1 reference

8 December 2017

Philippe Besnard

9

1 reference

8 December 2017

language of work or name

English

0 references

publication date

27 August 2004

1 reference

Journal of Biological Chemistry

8 December 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

8 December 2017

volume

279

1 reference

8 December 2017

issue

44

1 reference

8 December 2017

page(s)

45512-45518

1 reference

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

HDL-C and triglyceride levels: relationship to coronary heart disease and treatment with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

The lipid and non-lipid effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Effects of statins on triglyceride metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Cytoplasmic fatty acid-binding proteins: their structure and genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Liver fatty acid-binding protein expression in transfected fibroblasts stimulates fatty acid uptake and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Variation of liver-type fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Decreased Hepatic Triglyceride Accumulation and Altered Fatty Acid Uptake in Mice with Deletion of the Liver Fatty Acid-binding Protein Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1alpha (HNF1alpha). Alterations in fatty acid homeostasis in HNF1alpha-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Up-regulation of the expression of the gene for liver fatty acid-binding protein by long-chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Governance of the concentration of plasma LDL: a reevaluation of the LDL receptor paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

9-cis-retinoic acid enhances fatty acid-induced expression of the liver fatty acid-binding protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Selective activation of the JNK signaling cascadeand c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Reduction in hepatic non-esterified fatty acid concentration after long-term treatment with atorvastatin lowers hepatic triglyceride synthesis and its secretion in sucrose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Efficacy of atorvastatin and gemfibrozil, alone and in low dose combination, in the treatment of diabetic dyslipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

Pharmacotherapy for dyslipidaemia – current therapies and future agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407461200

21 January 2018

Identifiers

DOI

10.1074/JBC.M407461200

1 reference

8 December 2017

1 reference